Drugs / Phlogenzym
last change Jun 1997 re-read 3 minutes ago

Phlogenzym

Developed for
thrombophlebitis
Investigated by
Mucos Pharma GmbH & Co. KG

Trials 1

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03470337 Sep 1996 → Jun 1997 thrombophlebitis Mucos Pharma GmbH & Co. KG Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Phlogenzym ClinicalTrials.gov intervention name — accepted as the source's own label NCT03470337 ↗
Route Oral “Oral enzyme therapy” NCT03470337 ↗